Compounds > 1,3-dipropyl-8-cyclopentylxanthine

1,3-dipropyl-8-cyclopentylxanthine and mre 3008-f20

1,3-dipropyl-8-cyclopentylxanthine has been researched along with mre 3008-f20 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baraldi, PG; Borea, PA; Cacciari, B; Gessi, S; Klotz, KN; Leung, E; Merighi, S; Romagnoli, R; Spalluto, G; Varani, K1
Baraldi, PG; Borea, PA; Ferrari, D; Gessi, S; Leung, E; Merighi, S; Morelli, A; Spalluto, G; Varani, K1
Borea, PA; Cattabriga, E; Gessi, S; Iannotta, V; Leung, E; Merighi, S; Ulouglu, C; Varani, K1

Other Studies

3 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and mre 3008-f20

ArticleYear
[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
    Molecular pharmacology, 2000, Volume: 57, Issue:5

    Topics: Adenosine; Adenylyl Cyclase Inhibitors; Animals; Binding, Competitive; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Phenylurea Compounds; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptor, Adenosine A3; Receptors, Purinergic P1; Triazoles; Tritium

2000
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.
    British journal of pharmacology, 2001, Volume: 134, Issue:1

    Topics: Animals; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Guanosine Triphosphate; Humans; Jurkat Cells; Kinetics; Phenylurea Compounds; Purinergic P1 Receptor Agonists; Pyrimidines; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Thermodynamics; Time Factors; Triazoles; Tritium; Xanthines

2001
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line.
    British journal of pharmacology, 2001, Volume: 134, Issue:6

    Topics: Adenosine Deaminase; Binding, Competitive; Calcium; Cell Membrane; Cyclic AMP; Humans; Melanoma, Experimental; Phenylurea Compounds; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Triazoles; Tritium; Tumor Cells, Cultured; Xanthines

2001